Butorphanol Tartrate Injection, Solution
Product Images NDC 0143-9864

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Butorphanol Tartrate (NDC 0143-9864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Butorphanol Tartrate Injection 1)

Chemical structure diagram of Butorphanol Tartrate showing its molecular framework with ring systems and functional groups. The image also includes a simplified structural formula of the tartrate moiety associated with the compound.*

FDA Label Image

Plasma Levels (Butorphanol Tartrate Injection 2)

A pharmacokinetic line graph depicting plasma concentration (ng/mL, logarithmic scale) over time (hours) in subjects after intravenous (IV), nasal spray (NS), and intramuscular (IM) administration of Butorphanol Tartrate injection. The graph compares plasma concentration decline across three administration routes over 12 hours.*

FDA Label Image

Ndc 0143-9864-10 Civ Butorphanol Tartrate Injection, Usp 1 mg/ml For Iv Or Im Use Rx Only 1 mL Single Dose Vial Usual Dosage: See Pacakge Insert. (Butorphanol Tartrate Injection 3)

Label for Butorphanol Tartrate Injection, USP 1 mg/mL single dose vial for intramuscular or intravenous use. The label shows NDC 0143-9864-10 and indicates that the product is distributed by West-Ward Pharmaceutical Corp, Eatontown, NJ and manufactured by Hikma Farmaceutica, Portugal. It advises that dosage instructions are on the package insert.*

FDA Label Image

Ndc 0143-9867-10 Civ Butorphanol Tartrate Injection, Usp 2 mg/ml For Iv Or Im Use Rx Only 1 mL Single Dose Vial Usual Dosage: See Pacakge Insert. (Butorphanol Tartrate Injection 4)

Label for Butorphanol Tartrate Injection, USP 2 mg/mL in a 1 mL single dose vial. The label indicates it is for intravenous or intramuscular use, prescription only, and manufactured by Hikma Farmacêutica (Portugal), S.A., distributed by West-Ward Pharmaceutical Corp., Eatontown, NJ.*

FDA Label Image

Butorphanol Tartrate Injection 5

A label containing a QR code and text fields for GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The GTIN is shown as 00301234567896, SN as 1234567890123, expiration date as MMYYYY, and lot number as ABCDE12345. The label is likely used for traceability and identification of Butorphanol Tartrate Injection, solution by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.